Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMA-TB: Acetylsalicylic Acid and Ibuprofen as Adjunct Therapy for Tuberculosis
NCT04575519Phase 2Terminated
- Sponsor
- Germans Trias i Pujol Research Institute
- Start
- Mar 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of aspirin, ibuprofen in Tuberculosis (TB), multidrug-resistant tuberculosis (MDR-TB), sponsored by Germans Trias i Pujol Research Institute. Started Mar 2021; status: terminated.
02
Drugs
aspirinibuprofen
03
Conditions
Tuberculosis (TB)multidrug-resistant tuberculosis (MDR-TB)
Beyond the preview
Go deeper on NCT04575519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04575519.